30 related articles for article (PubMed ID: 6152104)
21. Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers.
Ortmann R; Bischoff S; Radeke E; Buech O; Delini-Stula A
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):265-70. PubMed ID: 6132341
[TBL] [Abstract][Full Text] [Related]
22. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
Arnt J; Hyttel J; Larsen JJ
Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):363-72. PubMed ID: 6152104
[TBL] [Abstract][Full Text] [Related]
23. Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.
Hyttel J
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):277-95. PubMed ID: 6128769
[TBL] [Abstract][Full Text] [Related]
24. [Which properties make a neuroleptic "atypical"?].
Gründer G; Vernaleken I; Benkert O
Nervenarzt; 2001 Nov; 72(11):833-43. PubMed ID: 11758090
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacological action of antipsychotic drugs].
Tokuda K
Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):173-6. PubMed ID: 16971781
[No Abstract] [Full Text] [Related]
26. Behavioral pharmacology of antagonists at 5-HT2/5-HT1C receptors.
Koek W; Jackson A; Colpaert FC
Neurosci Biobehav Rev; 1992; 16(1):95-105. PubMed ID: 1553110
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
